Premenopausal women and men with endocrine- or medication-related risks for osteoporosis may be affected, and timely bone ...

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics’ commitment to ...

CAREFNDR underscores the potential clinical value of paltusotine beyond acromegaly, and demonstrates progress in Crinetics' commitment to addressing unmet needs in the neuroendocrine tumor community ...

Adverse changes in the heart’s structure and function are common in people with chronic kidney disease (CKD), warranting mitigating therapies.

The REMODEL trial testing semaglutide’s efficacy in patients with CKD and T2DM also employed MRI, transcriptomics, blood and urine samples, and kidney biopsies to clarify the drug’s effects.

Primary hyperparathyroidism (pHPT) was associated with long-term cardiometabolic risks, but the risk of type 2 diabetes was ...

In this retrospective study of 9 cases of surgically managed primary hyperparathyroidism, we aimed to examine the ...